Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,145 | 63,547 | 286,805 | 275,484 | 325,680 |
| Marketable Securities | 111,944 | 128,134 | N/A | N/A | N/A |
| Receivables | 101,458 | 109,964 | 91,186 | 115,711 | 117,039 |
| Inventories | 49,406 | 38,791 | 27,719 | 31,744 | 36,945 |
| Other current assets | 20,954 | 22,918 | 21,932 | 16,669 | 19,361 |
| TOTAL | $315,926 | $381,234 | $448,275 | $446,784 | $512,443 |
| Non-Current Assets | |||||
| PPE Net | 7,724 | 8,754 | 9,571 | 9,553 | 7,998 |
| Intangibles | 0 | 5,931 | 0 | 0 | 0 |
| Other Non-Current Assets | 78,776 | 84,928 | 93,061 | 89,666 | 72,946 |
| TOTAL | $86,500 | $99,613 | $102,632 | $99,219 | $80,944 |
| Total Assets | $402,426 | $480,847 | $550,907 | $546,003 | $593,387 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 23,231 | 11,526 | 9,917 | 17,486 | 21,092 |
| Accrued Expenses | 100,176 | 127,168 | 161,402 | 123,268 | 132,656 |
| TOTAL | $123,407 | $138,694 | $171,319 | $140,754 | $153,748 |
| Non-Current Liabilities | |||||
| Long Term Debt | 245,718 | 245,483 | 245,246 | 196,037 | 195,849 |
| Other Non-Current Liabilities | 229,808 | 234,088 | 231,475 | 231,841 | 231,227 |
| TOTAL | $475,526 | $479,571 | $476,721 | $427,878 | $427,076 |
| Total Liabilities | $598,933 | $618,265 | $648,040 | $568,632 | $580,824 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 80,554 | 79,610 | 77,778 | 77,725 | 77,423 |
| Common Shares | 8 | 8 | 7 | 7 | 7 |
| Retained earnings | -1,417,337 | -1,341,608 | -1,282,738 | -1,196,088 | -1,145,938 |
| Other shareholders' equity | -278 | -249 | -270 | -270 | -272 |
| TOTAL | $-196,507 | $-137,418 | $-97,133 | $-22,629 | $12,563 |
| Total Liabilities And Equity | $402,426 | $480,847 | $550,907 | $546,003 | $593,387 |